scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1091398751 |
P356 | DOI | 10.1007/S00592-017-1042-6 |
P932 | PMC publication ID | 5643352 |
P698 | PubMed publication ID | 28856555 |
P50 | author | Piotr Jurowski | Q20029264 |
Anna Niwald | Q20029965 | ||
Wojciech Młynarski | Q30903317 | ||
Arleta Waszczykowska | Q86614507 | ||
Wojciech Fendler | Q87899299 | ||
Agnieszka Zmyslowska | Q88962391 | ||
Maciej Borowiec | Q91659362 | ||
P2860 | cites work | Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells | Q24299603 |
Optical coherence tomography as a biomarker in multiple sclerosis | Q30597564 | ||
Morphological changes in spectral domain optical coherence tomography guided bevacizumab injections in wet age-related macular degeneration, 12-months results | Q33785965 | ||
Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. | Q34719042 | ||
Morbidity and mortality in the Wolfram syndrome | Q34733998 | ||
EURO-WABB: an EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome | Q34975099 | ||
Retinal thinning and correlation with functional disability in patients with Parkinson's disease | Q35052814 | ||
Impairment of visual function and retinal ER stress activation in Wfs1-deficient mice. | Q35167762 | ||
Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome | Q35764708 | ||
Glycemic variability in patients with Wolfram syndrome is lower than in type 1 diabetes | Q36234364 | ||
Signal quality assessment of retinal optical coherence tomography images | Q37716566 | ||
Identification of four novel mutations of the WFS1 gene in Iranian Wolfram syndrome pedigrees | Q38842178 | ||
Optical coherence tomography: clinical applications in medical practice | Q39891294 | ||
Ophthalmologic findings in fifteen patients with Wolfram syndrome | Q44001399 | ||
Wolfram syndrome 2: a novel CISD2 mutation identified in Italian siblings. | Q45181218 | ||
Pigmentary maculopathy in a patient with Wolfram syndrome | Q46931451 | ||
Optic disc and retinal nerve fiber layer parameters as indicators of neurodegenerative brain changes in patients with obstructive sleep apnea syndrome | Q48180041 | ||
WFS1 in Optic Neuropathies: Mutation Findings in Nonsyndromic Optic Atrophy and Assessment of Clinical Severity. | Q50349033 | ||
Wolfram syndrome in the Polish population: novel mutations and genotype-phenotype correlation | Q50434019 | ||
Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. | Q51920606 | ||
Association of optic atrophy and type 1 diabetes: clinical hallmarks for the diagnosis of Wolfram syndrome | Q58866601 | ||
Retinal thinning as a marker of disease progression in patients with Wolfram syndrome | Q86830438 | ||
Delayed recognition of Wolfram syndrome frequently misdiagnosed as type 1 diabetes with early chronic complications | Q87166776 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P304 | page(s) | 1019-1024 | |
P577 | publication date | 2017-08-30 | |
P1433 | published in | Acta Diabetologica | Q15749690 |
P1476 | title | Retinal thickness as a marker of disease progression in longitudinal observation of patients with Wolfram syndrome | |
P478 | volume | 54 |
Q57455268 | Measurement of corneal thickness, optic nerve sheath diameter and retinal nerve fiber layer as potential new non-invasive methods in assessing a risk of cerebral edema in type 1 diabetes in children |
Q92480980 | Novel mutations and the ophthalmologic characters in Chinese patients with Wolfram Syndrome |
Q88366333 | Visual pathway function and structure in Wolfram syndrome: patient age, variation and progression |
Q52670688 | [Structural endpoints for glaucoma studies]. |
Search more.